Literature DB >> 33725968

Breast tubular carcinoma at parasternal and retro-nipple area: Two case reports.

Junhua Shi1, Junli Shi1, Shengbo Yang2.   

Abstract

INTRODUCTION: Breast tubular carcinoma (TC) is a well-differentiated infiltrating ductal carcinoma, common in postmenopausal women. PATIENT CONCERNS: Two patients concerned their abnormality of their breasts, one at deep parasternal higher chest wall in a 74-year-old female and the other behind the nipple in a 39- year-old female. DIAGNOSIS: These masses were detected by mammography, ultrasound and magnetic resonance imaging (MRI) examinations. The parasternal mass identified by mammography showed long spicules along the edges of the mass. Ultrasound examination revealed that these masses had solid irregular hypoechoic nodules. The color Doppler ultrasound of the retro-nipple mass presented with increased blood flow resistance index. The dynamic contrast-enhanced MRI examination of the retro-nipple nodule demonstrated an intensely enhancing mass with a plateau-type time-signal intensity curve.
INTERVENTIONS: Two cases were surgically removed by local resection of foci under ultrasound guidance. OUTCOMES: These imaging examinations strongly suggest possible breast tubular carcinoma, which was confirmed by the pathological evaluation of frozen sections from surgically removed masses.
CONCLUSION: Although uncommon, breast tubular carcinoma may be considered in the differential diagnosis of small solid masses with long spicules at parasternal breast or behind the nipples in adult women.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Year:  2021        PMID: 33725968      PMCID: PMC7982237          DOI: 10.1097/MD.0000000000024977

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  16 in total

1.  Correlation between ultrasound characteristics, mammographic findings and histological grade in patients with invasive ductal carcinoma of the breast.

Authors:  P M Lamb; N M Perry; S J Vinnicombe; C A Wells
Journal:  Clin Radiol       Date:  2000-01       Impact factor: 2.350

2.  The ultrastructure of tubular carcinoma of the breast.

Authors:  M Harris; A Ahmed
Journal:  J Pathol       Date:  1977-10       Impact factor: 7.996

3.  Unusual presentation of tubular carcinoma of the breast.

Authors:  Stuart S Kaplan; Sherry Thompson; Fernando Collado-Mesa; Robert J Poppiti; Katrina Rabinovich; Adrian Legaspi
Journal:  Breast J       Date:  2011-06-17       Impact factor: 2.431

4.  Tubular carcinoma of the breast: institutional and SEER database analysis supporting a unique classification.

Authors:  Andrew M Romano; Nolan A Wages; Mark Smolkin; Kristin La Fortune; Kristen Atkins; Patrick M Dillon
Journal:  Breast Dis       Date:  2015

Review 5.  Tubular carcinoma of the breast: pathological, clinical, and ultrasonographic findings. A review of the literature.

Authors:  F Zandrino; M Calabrese; C Faedda; F Musante
Journal:  Radiol Med       Date:  2006-08-11       Impact factor: 3.469

6.  Tubular carcinoma of the breast: mammographic, sonographic, clinical and pathologic findings.

Authors:  Işil Günhan-Bilgen; Ayşenur Oktay
Journal:  Eur J Radiol       Date:  2006-09-20       Impact factor: 3.528

7.  Radial scar and tubular carcinoma of the breast.

Authors:  S Tükel; S Koçak; S Aydintuğ; S Erekul; G Akyar
Journal:  Australas Radiol       Date:  1997-05

Review 8.  Unusual breast cancers: useful clues to expanding the differential diagnosis.

Authors:  Jennifer A Harvey
Journal:  Radiology       Date:  2007-03       Impact factor: 11.105

9.  Tubular carcinoma of the breast: mammographic appearance.

Authors:  A J Leibman; M Lewis; B Kruse
Journal:  AJR Am J Roentgenol       Date:  1993-02       Impact factor: 3.959

10.  Tubular carcinoma of the breast: further evidence to support its excellent prognosis.

Authors:  Emad A Rakha; Andrew H S Lee; Andrew J Evans; Sindhu Menon; Nancy Y Assad; Zsolt Hodi; Douglas Macmillan; Roger W Blamey; Ian O Ellis
Journal:  J Clin Oncol       Date:  2009-11-16       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.